![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
Amir Fathi, MD
Leukemia Specialist
Specialities: Acute Myeloid Leukemia, Myelodysplastic Syndromes
Spoken languages: English
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
more_vert
Clinical Expertise
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
About
Dr. Fathi focuses his research on the development and clinical translation of novel therapies for acute leukemias. He currently leads multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies. He has a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.
Location
Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA
Get the Latest Myelodysplastic Syndromes Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.